Investors purchased shares of CME Group Inc (NASDAQ:CME) on weakness during trading on Tuesday. $54.69 million flowed into the stock on the tick-up and $31.18 million flowed out of the stock on the tick-down, for a money net flow of $23.51 million into the stock. Of all companies tracked, CME Group had the 21st highest net in-flow for the day. CME Group traded down ($1.26) for the day and closed at $144.79
A number of analysts recently commented on CME shares. Barclays started coverage on CME Group in a research note on Friday, September 8th. They issued an “overweight” rating and a $139.00 price target for the company. UBS Group reaffirmed a “buy” rating and issued a $135.00 price target (up previously from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, September 13th. Citigroup raised their price target on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, October 19th. Finally, Wells Fargo & Co raised their price target on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research note on Wednesday, October 4th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. CME Group presently has an average rating of “Buy” and a consensus price target of $144.22.
The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. The firm has a market capitalization of $50,720.00, a price-to-earnings ratio of 33.80, a PEG ratio of 2.61 and a beta of 0.72.
The company also recently disclosed a dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Thursday, December 28th will be issued a $3.50 dividend. This is an increase from CME Group’s previous dividend of $3.25. The ex-dividend date of this dividend is Wednesday, December 27th. CME Group’s dividend payout ratio is 59.86%.
In other CME Group news, insider Sunil Cutinho sold 2,600 shares of the firm’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $139.57, for a total value of $362,882.00. Following the transaction, the insider now directly owns 22,301 shares of the company’s stock, valued at $3,112,550.57. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jack J. Tobin sold 2,325 shares of the firm’s stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $152.28, for a total value of $354,051.00. Following the completion of the transaction, the insider now directly owns 17,574 shares in the company, valued at $2,676,168.72. The disclosure for this sale can be found here. In the last quarter, insiders sold 37,603 shares of company stock valued at $5,456,551. 0.57% of the stock is owned by corporate insiders.
Several hedge funds have recently bought and sold shares of CME. Fiduciary Trust Co. bought a new stake in CME Group during the 2nd quarter valued at approximately $105,000. Quadrant Capital Group LLC raised its stake in CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares during the period. Valeo Financial Advisors LLC bought a new stake in CME Group during the 3rd quarter valued at approximately $124,000. San Francisco Sentry Investment Group CA bought a new stake in CME Group during the 2nd quarter valued at approximately $129,000. Finally, People s United Financial Inc. raised its stake in CME Group by 11.5% during the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares during the period. 82.70% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3125642/investors-buy-shares-of-cme-group-cme-on-weakness.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.